Related Experiment Video

Updated: May 29, 2026

Measuring Caspase Activity Using a Fluorometric Assay or Flow Cytometry
05:29

Measuring Caspase Activity Using a Fluorometric Assay or Flow Cytometry

Published on: March 24, 2023

Cell death induced by novel procaspase-3 activators can be reduced by growth factors

Karen A Boldingh Debernard1, Gulzeb Aziz, Annine Thomassen Gjesvik

  • 1Department of Pharmaceutical Biosciences, School of Pharmacy, University of Oslo, Oslo, Norway.

Biochemical and Biophysical Research Communications
|September 7, 2011
PubMed

Insights

Epidermal growth factor (EGF) blocks the cancer drug PAC-1 from activating caspase-3 and protects cells from death. This suggests growth factor signaling may complicate cancer therapy with caspase-3 activators.

Area of Science:

  • Cellular biology
  • Apoptosis research
  • Cancer therapeutics

Background:

  • Caspase-3 is a key enzyme in apoptosis, crucial for programmed cell death.
  • Procaspase-activating compound-1 (PAC-1) and 1541 activate caspase-3, showing potential as cancer treatments.
  • Cellular regulation of caspase-3 activation is complex and not fully understood.

Purpose of the Study:

  • To investigate the effect of epidermal growth factor (EGF) on PAC-1-induced caspase-3 activity and cell death.
  • To explore the interaction between growth factor signaling and caspase-3 activation.
  • To assess the implications for cancer therapy.

Main Methods:

  • Utilized PC12 cells and primary cerebellar granule neurons.
  • Administered PAC-1 and 1541 to induce caspase-3 activity and cell death.
  • Investigated the impact of epidermal growth factor (EGF) on these processes.
  • Measured cellular p-ERK levels.

Main Results:

  • EGF inhibited PAC-1-induced caspase-3 activity.
  • EGF protected cells from PAC-1-induced death.
  • Similar effects were observed with compound 1541.
  • Both PAC-1 and 1541 reduced cellular p-ERK levels.

Conclusions:

  • EGF signaling can counteract the effects of direct caspase-3 activators like PAC-1.
  • Crosstalk between caspase-3 and growth factor pathways poses challenges for cancer therapy.
  • Understanding these cellular interactions is vital for developing effective caspase-based treatments.

More Related Videos

Evaluation of Caspase Activation to Assess Innate Immune Cell Death10:23

Evaluation of Caspase Activation to Assess Innate Immune Cell Death

Published on: January 20, 2023

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

Related Concept Videos

Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...